comparemela.com

Latest Breaking News On - National expert group on vaccine administration - Page 12 : comparemela.com

SII seeks approval for Covishield vaccine as booster dose amid Omicron variant concerns

The Serum Institute of India (SII) has sought India drug regulator approval for the Covishield vaccine as a booster dose citing adequate stock of the vaccin

South-africa
Karnataka
India
Chhattisgarh
Kerala
South-african
Adar-poonawalla
World-health-organization
National-expert-group-on-vaccine-administration
National-technical-advisory-group-on-immunization
Serum-institute-of-india
Shalini-bhardwajnew-delhi

SII seeks approval for Covishield vaccine as booster dose amid Omicron variant concerns

The Serum Institute of India (SII) has sought India drug regulator approval for the Covishield vaccine as a booster dose citing adequate stock of the vaccin

South-africa
Karnataka
India
Chhattisgarh
Kerala
South-african
Adar-poonawalla
World-health-organization
National-expert-group-on-vaccine-administration
National-technical-advisory-group-on-immunization
Serum-institute-of-india
Shalini-bhardwajnew-delhi

SII seeks approval for Covishield vaccine as booster dose amid Omicron variant concerns

The Serum Institute of India (SII) has sought India drug regulator approval for the Covishield vaccine as a booster dose citing adequate stock of the vaccin

South-africa
Karnataka
India
Chhattisgarh
Kerala
South-african
Adar-poonawalla
World-health-organization
National-expert-group-on-vaccine-administration
National-technical-advisory-group-on-immunization
Serum-institute-of-india
Shalini-bhardwajnew-delhi

SII seeks approval for Covishield vaccine as booster dose amid Omicron variant concerns

The Serum Institute of India (SII) has sought India drug regulator approval for the Covishield vaccine as a booster dose citing adequate stock of the vaccin

South-africa
Karnataka
India
Chhattisgarh
Kerala
South-african
Adar-poonawalla
World-health-organization
National-expert-group-on-vaccine-administration
National-technical-advisory-group-on-immunization
Serum-institute-of-india
Shalini-bhardwajnew-delhi

SII seeks approval for Covishield vaccine as booster dose amid Omicron variant concerns

The Serum Institute of India (SII) has sought India drug regulator approval for the Covishield vaccine as a booster dose citing adequate stock of the vaccin

South-africa
Karnataka
India
Chhattisgarh
Kerala
South-african
Adar-poonawalla
World-health-organization
National-expert-group-on-vaccine-administration
National-technical-advisory-group-on-immunization
Serum-institute-of-india
Shalini-bhardwajnew-delhi

vimarsana © 2020. All Rights Reserved.